Atticus Wealth Management’s Guardant Health GH Stock Holding History

Atticus Wealth Management’s Portfolio GH Stock Details GH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-500	Closed	-$33K	–	611
2022 Q1	$33K	Buy	500 +100	+25%	+$6.84K	0.01%	286
2021 Q4	$40K	Hold	400	–	–	0.02%	250
2021 Q3	$50K	Hold	400	–	–	0.02%	232
2021 Q2	$50K	Hold	400	–	–	0.02%	230
2021 Q1	$61K	Hold	400	–	–	0.03%	196
2020 Q4	$52K	Hold	400	–	–	0.03%	209
2020 Q3	$45K	Hold	400	–	–	0.03%	180
2020 Q2	$32K	Hold	400	–	–	0.02%	193
2020 Q1	$28K	Sell	400 -100	-20%	-$7.67K	0.02%	190
2019 Q4	$39K	Buy	+500	New	+$36K	0.02%	190

Other funds holding GH

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Atticus Wealth Management's GH Position: Q2 2022 in Review

Atticus Wealth Management sold out of Guardant Health (GH) in Q2 2022, closing a stake of 500 shares — an estimated $33K sold.

Atticus Wealth Management first reported a position in GH in Q4 2019 and held it in 10 quarters. The position peaked at $61K in Q1 2021. 332 funds tracked by Wall St. Rank hold GH as of Q2 2022.

Atticus Wealth Management reported no remaining Guardant Health position as of Q2 2022 after selling out during the quarter.
Atticus Wealth Management sold 500 Guardant Health shares in Q2 2022, an estimated $33K.
Atticus Wealth Management first reported a position in Guardant Health in Q4 2019 and held it in 10 quarters.
Atticus Wealth Management's Guardant Health position peaked at $61K in Q1 2021.
332 funds tracked by Wall St. Rank held Guardant Health as of Q2 2022.

Based on Atticus Wealth Management's 13F filing for Q2 2022, filed 13 Jul 2022.